This project examined the use of an e-prescribing system, with medication management clinical support, on the health of hypertensive patients.
Planned the implementation of an HIE using a secure fiber optic connection between community care providers to share patient demographic, medical records, laboratory results, and radiographic images.
This project was one of the Centers for Education and Research on Therapeutics’ projects, a national initiative to increase awareness of the benefits and risks of new, existing, or combined uses of therapeutics through education and research.
This project developed two e-Prescribing implementation toolsets, one for independent pharmacies, and the other for health care provider organizations.
Added a health care portal to the existing community-wide electronic data exchange which will allow for use of the current electronic messaging system along with migration to a full EMR; evaluated physician office efficiency improvement and cost reduction, payer return on investment, and safety and quality improvement.
Facilitates transfer of information among providers and patients in the Presque Isle community; implements a model of chronic care management; and educates area health care providers on how best to use current information systems to communicate with each other.
This project designed, developed, piloted, and studied an e-Prescribing utility called Rx Gateway.
This project looked at the integration of patient-centered interventions targeting patients, their providers, and their health care organization in an attempt to improve the medication management process.
This study evaluated the impact of a widely used e-prescribing system in order to understand characteristics of successful e-prescribing adoption.
Implemented an ambulatory computer physician order entry (ACPOE) system with clinical decision support capabilities in an ambulatory, community-based, integrated health-system; evaluated the impact of the system both internally, on organizational processes and human factors, and externally, on patient safety as measured by medication errors and adverse drug events.
